Intellectual Capital and Competitive Advantages : The Case of Tty Biopharm Company

By conducting indepth interviews with CEO and top management of TTY Biopharm Company, a Taiwan-based pharmaceutical company, I depict the role of TTY's intellectual capital in building competitive advantages and enhancing the achievement of corporate strategies. TTY's success illustrates that even in a relatively small pharmaceutical market such as Taiwan, where a full-range new drug R&D, covering from discovering new chemicals to developing new drugs, seems economically infeasible, adopting fit R&D strategies and developing intellectual capital to establish competitive advantages can overcome the limitations in home market size and bear fruitful results